InnoCare Pharma Limited (OTCMKTS:INCPF) Sees Significant Growth in Short Interest

InnoCare Pharma Limited (OTCMKTS:INCPF) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 2,943,400 shares, an increase of 8.4% from the March 31st total of 2,714,400 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

InnoCare Pharma Stock Performance

Shares of INCPF opened at $3.26 on Thursday. The company’s 50 day simple moving average is $3.26 and its 200-day simple moving average is $3.26. InnoCare Pharma has a 12-month low of $3.26 and a 12-month high of $3.72.

InnoCare Pharma Company Profile

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.